These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3481177)

  • 1. Bioequivalence of Genotropin and Somatonorm.
    Wilton P; Widlund L; Guilbaud O
    Acta Paediatr Scand Suppl; 1987; 337():118-21. PubMed ID: 3481177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relative Bioavailability of a Single 4-mg Dose of Somatropin Administered by Subcutaneous Injection or by Needle-free Device and Coadministered With the Growth Hormone Inhibitor Octreotide Acetate in Healthy Adult Subjects.
    Brimhall DB; Petri N; D'Angelo P
    Clin Ther; 2018 May; 40(5):741-751. PubMed ID: 29699852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of recombinant human growth hormone administered by cool.click 2, a new needle-free device, compared with subcutaneous administration using a conventional syringe and needle.
    Brearley C; Priestley A; Leighton-Scott J; Christen M
    BMC Clin Pharmacol; 2007 Oct; 7():10. PubMed ID: 17922895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subcutaneous absorption kinetics of two highly concentrated preparations of recombinant human growth hormone.
    Laursen T; Jørgensen JO; Susgaard S; Møller J; Christiansen JS
    Ann Pharmacother; 1993 Apr; 27(4):411-5. PubMed ID: 8477114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioavailability of recombinant human growth hormone in different concentrations and formulations.
    Vahl N; Jensen SB; Rasmussen MH; Susgaard S; Jørgensen JO; Christiansen JS; Rasmussen UF; Hilsted J
    Pharmacol Toxicol; 1996 Sep; 79(3):144-9. PubMed ID: 8884873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Results of the treatment of growth hormone deficiency with methionine-somatotropin or recombinant somatotropin].
    Dorantes-Alvarez LM
    Bol Med Hosp Infant Mex; 1990 Jun; 47(6):369-71. PubMed ID: 2222818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Equivalent potency and pharmacokinetics of recombinant human growth hormones with or without an N-terminal methionine.
    Moore JA; Rudman CG; MacLachlan NJ; Fuller GB; Burnett B; Frane JW
    Endocrinology; 1988 Jun; 122(6):2920-6. PubMed ID: 3371267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioequivalence of subcutaneous injections of recombinant human follicle stimulating hormone (Puregon(R)) by Pen-injector and syringe.
    Voortman G; van de Post J; Schoemaker RC; van Gerven JM
    Hum Reprod; 1999 Jul; 14(7):1698-702. PubMed ID: 10402370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioequivalence between ready-to-use recombinant human growth hormone (rhGH) in liquid formulation and rhGH for reconstitution.
    Jacobsen LV; Rolan P; Christensen MS; Knudsen KM; Rasmussen MH
    Growth Horm IGF Res; 2000 Apr; 10(2):93-8. PubMed ID: 10931747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioequivalence studies of omnitrope, the first biosimilar/rhGH follow-on protein: two comparative phase 1 randomized studies and population pharmacokinetic analysis.
    Stanhope R; Sörgel F; Gravel P; Pannatier Schuetz YB; Zabransky M; Muenzberg M
    J Clin Pharmacol; 2010 Nov; 50(11):1339-48. PubMed ID: 20173088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative pharmacokinetic and pharmacodynamic evaluation between a new biosimilar and reference recombinant human growth hormone.
    Toffoletto O; Afiune J; Thiemann JE; Khandave SS; Patel S; Rodrigues DG
    Growth Horm IGF Res; 2016; 30-31():31-36. PubMed ID: 27657985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relative bioavailability of two drug products of somatropin obtained from either the milk of transgenic cows or bacterial culture.
    Farías J; Feleder E; González E; Halabe K; Criscuolo ME; Bergadá I; Diez RA
    Horm Res Paediatr; 2010; 73(4):258-64. PubMed ID: 20215772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human growth hormone produced with recombinant DNA technology: development and production.
    Flodh H
    Acta Paediatr Scand Suppl; 1986; 325():1-9. PubMed ID: 3296632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioequivalence of recombinant human FSH and recombinant human LH in a fixed 2:1 combination: two phase I, randomised, crossover studies.
    Picard M; Rossier C; Papasouliotis O; Lugan I
    Curr Med Res Opin; 2008 Apr; 24(4):1199-208. PubMed ID: 18348746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tolerability and pharmacokinetic properties of ondansetron administered subcutaneously with recombinant human hyaluronidase in minipigs and healthy volunteers.
    Dychter SS; Harrigan R; Bahn JD; Printz MA; Sugarman BJ; DeNoia E; Haughey DB; Fellows D; Maneval DC
    Clin Ther; 2014 Feb; 36(2):211-24. PubMed ID: 24486335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are needle-free injections a useful alternative for growth hormone therapy in children? Safety and pharmacokinetics of growth hormone delivered by a new needle-free injection device compared to a fine gauge needle.
    Dörr HG; Zabransky S; Keller E; Otten BJ; Partsch CJ; Nyman L; Gillespie BK; Lester NR; Wilson AM; Hyrén C; van Kuijck MA; Schuld P; Schoenfeld SL
    J Pediatr Endocrinol Metab; 2003 Mar; 16(3):383-92. PubMed ID: 12705363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Present situation worldwide regarding the use and clinical experience of Somatonorm (somatrem).
    Flodh H
    Acta Paediatr Scand Suppl; 1987; 331():1-4. PubMed ID: 3300150
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical experience with somatrem in Japan.
    Takano K; Shizume K
    Acta Paediatr Scand Suppl; 1986; 325():19-24. PubMed ID: 3296635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update on the clinical use and experience of Somatonorm (somatrem).
    Flodh H
    Acta Paediatr Scand Suppl; 1987; 337():130-3. PubMed ID: 3481179
    [No Abstract]   [Full Text] [Related]  

  • 20. A comparison of the bioequivalence of two formulations of epoetin alfa after subcutaneous injection.
    Togawa A; Tanaka T; Nagashima S; Keta H; Kobayashi Y; Nishikawa Y; Yanai M; Tanaka H
    Br J Clin Pharmacol; 2004 Sep; 58(3):269-76. PubMed ID: 15327586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.